Skip to main content

Day: December 18, 2023

Telemedicine Market Size, Share & Growth Analysis, [2030] | With CAGR of 17.2%

As per the report by Fortune Business Insights, the Telemedicine Market size is projected to reach USD 286.22 Billion by 2030, at a CAGR of 17.2%.Telemedicine_MarketTelemedicine Market (2023-2030)Pune, India, Dec. 18, 2023 (GLOBE NEWSWIRE) — The global telemedicine market size is calculated worth USD 94.44 Billion in 2023, and it is projected to reach USD 286.22 Billion by 2030, registering a compound annual growth rate (CAGR) of 17.2% from 2023 to 2030. Furthermore, in 2022, the market was estimated to be worth USD 87.41 Billion. The increasing prevalence of chronic diseases and growing out-of-pocket expenditures have led to a significant rise in healthcare cost. According to the Centers for Medicare and Medicaid Services. Furthermore, a rising preference for remote patient monitoring using technologically advanced products...

Continue reading

Medical Devices Market Size, Share & Growth Analysis, [2030] | With CAGR of 5.9%

The global medical device market is expected to reach USD 799.67 billion by 2030, growing at a compound annual growth rate of 5.9% throughout the forecast period, according to a Fortune Business Insights analysis.Medical Devices MarketMedical Devices Market (2023-2030)Pune, India, Dec. 18, 2023 (GLOBE NEWSWIRE) — The size of the global medical devices market is expected to grow at a compound annual growth rate (CAGR) of 5.9%, from USD 536.12 billion in 2023 to USD 799.67 billion. The surge is driven by the escalating emphasis of healthcare agencies toward early treatment and diagnosis and an increasing number of patients undergoing surgical and diagnostic procedures. The market growth is further propelled by the escalating investments in R&D by key industry players for the development of technologically advanced...

Continue reading

Network as a Service Market Size, Share & Growth Analysis, [2030] | With CAGR of 35.3%

At 35.3% CAGR, the global Network as a Service Market size is projected to reach USD 155.17 billion by 2030Network as a Service MarketForecast, 2023-2030Pune,India, Dec. 18, 2023 (GLOBE NEWSWIRE) — Global network as a service market size was valued at USD 13.63 billion in 2022 and is projected to reach USD 155.17 billion by 2030, exhibiting a CAGR of 35.3% during the forecast period. Factors such as increased adoption of cloud technology from BFSI and IT & telecommunication along with an increasing portfolio of services will boost the growth of the market during the forecast period. Additionally, increased adoption of technology by SMEs and large-scale organizations will increase the footprint of the market. This information is provided by Fortune Business Insights™ in its research report titled Network...

Continue reading

Customer Experience Management Market Size, Share & Growth Analysis, [2030] | With CAGR of 16.6%

At 16.6% CAGR, the global Customer Experience Management Market size is projected to reach USD 52.54 billion by 2030Customer Experience Management MarketForecast 2023 – 2030Pune,India, Dec. 18, 2023 (GLOBE NEWSWIRE) — Global customer experience management market size was valued at USD 14.95 billion in 2022 and is projected to reach USD 52.54 billion by 2030, exhibiting a CAGR of 16.6% during the forecast period. CEM tools can also help companies increase their brand awareness, further accelerating the customer experience management market growth. High usage of AI and AR across sectors to accelerate the market. Fortune Business Insights, provide this information in its report titled, Global Customer Experience Management Market Forecast, 2024-2030.Request a Free Sample PDF:   https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/customer-experience-management-cem-market-101661Key...

Continue reading

U.S. Food and Drug Administration Issues Complete Response Letter for Cosibelimab Solely Due to Inspection Findings at Third-Party Manufacturer

FDA did not state any concerns about the clinical data package, safety, or labeling for the approvability of cosibelimab WALTHAM, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), today announced that the U.S. Food and Drug Administration (“FDA”) has issued a complete response letter (“CRL”) for the cosibelimab biologic license application (“BLA”) for the treatment of patients with metastatic or locally advanced cutaneous squamous cell carcinoma (“cSCC”) who are not candidates for curative surgery or radiation. The CRL only cites findings that arose during a multi-sponsor inspection of Checkpoint’s third-party contract manufacturing organization as approvability issues to address in a resubmission. The CRL did not state any concerns about the clinical data package, safety, or labeling...

Continue reading

Cipher Mining Purchases 7.1 EH/s of New Miners and Option to Purchase an Additional 8.7 EH/s of Latest Generation Miners from Bitmain

Purchases 7.1 EH/s of latest generation Bitmain T21 miners for $99.5 million, representing a unit price of $14/TH Secures option to purchase up to an additional 8.7 EH/s at the same fixed price terms Full purchase order and option would bring total hashrate in operation and under contract to 24.2 EH/s and overall potential fleet efficiency to 22.6 J/TH Purchase order and option provides a path to the initial buildout at Black Pearl and other near-term expansion opportunities in 2024 NEW YORK, Dec. 18, 2023 (GLOBE NEWSWIRE) — Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher”), a leading developer and operator of bitcoin mining data centers, announced today that it has entered into an agreement with Bitmain to purchase 37,396 units of the latest generation Antminer T21 miners, representing 7.1 EH/s of self-mining capacity to be delivered...

Continue reading

Red Pine Intersects Significant Mineralization within a gap of the existing resource – 3.80 g/t gold over 36.94m including 11.01 g/t gold over 5.60m

Figure 1Plan Map of the Drilling ResultsFigure 2Minto B Shear Zone in the Hanging Wall of the Surluga DepositTORONTO, Dec. 18, 2023 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”) continues to report new assay results from its ongoing exploration program. These new results expand the exploration potential at depth in the Jubilee Shear and continue to expand the footprint of gold mineralization within gaps/hole of the existing Surluga resource.Intersection of significant mineralization in the Jubilee Shear outside the footprint of the existing resource3.80 g/t gold over 36.94 metres including 24.04 g/t gold over 1.71 metres and 46.9 g/t gold over 1.04 metres in SD-23-456Extension of mineralization 370 metres down-dip of the existing resource and 400 metres...

Continue reading

Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Fourth Quarter of 2023

Declares Special Dividend of $0.29 per common share for 2023 Tax Year CHICAGO, Dec. 18, 2023 (GLOBE NEWSWIRE) — Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI), a commercial mortgage real estate investment trust, announced that its board of directors has declared a regular quarterly cash dividend of $0.47 per share for the fourth quarter of 2023. The regular quarterly dividend, which equates to an annualized rate of $1.88 per common share, is payable on January 12, 2024, to shareholders of record as of the close of business on December 29, 2023. The board of directors also declared a special cash dividend of $0.29 per share, which will be included in fiscal year 2023 taxable income for federal income tax purposes. The special dividend is payable on January 12, 2024, to shareholders of record as of the close of business...

Continue reading

Venus Concept Announces New International Distributors in the United Kingdom and India to Continue Global Growth

TORONTO, Dec. 18, 2023 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced the expansion of its international distributor network with the signing of two new exclusive partnerships: Core Aesthetics Skin & Laser Limited (“Core Aesthetics”) in the United Kingdom and Spectra Medical Systems (“Spectra”) in India. Both regions are high growth markets for the Company. The execution of these agreements represents an important step towards Venus Concept’s focus of driving international growth through strong distributor partnerships. “We are excited to continue developing our distributor network in important markets. This transition allows us to leverage local expertise to grow our revenues in these regions and...

Continue reading

MariMed’s Betty’s Eddies™ Celebrates a Decade of Handcrafted Deliciousness by Introducing a Limited-Edition Betty’s Bubbly Champagne Chew

NORWOOD, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) — Betty’s Eddies™, the all-natural cannabis fruit chews handcrafted to fit a variety of health and wellness needs, hits a milestone in 2024 that few cannabis edible brands can claim: 10 years of helping people feel their best. To celebrate the occasion, this month the brand is launching Betty’s Bubbly, a new, limited-edition batch of sparkling champagne chews. One of the top-selling and award-winning brands developed and distributed by leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), an estimated 35 million Betty’s Eddies fruit chews have been sold in six states and Puerto Rico since 2014. Available starting this month at MariMed’s six owned and operated dispensaries and hundreds of other cannabis retailers throughout Massachusetts,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.